Category North America

US-EU Transatlantic Trade Deal Would Skip IPRs

The Office of the United States Trade Representative (USTR) yesterday released an interim report with the European Union on ways to expand transatlantic trade and investment. But apparently this would not including trying to bridge differences on intellectual property rights.

Music Publishers, Universal Sign “Groundbreaking” Licence Deal

A trade association representing music publishers and songwriters today announced a model licensing deal with Universal Music Group that is expected to allow songwriters and publishers to share in the revenue from music videos. Universal is the first record label to make such an agreement, parties said.

Upcoming Event: 5th Product And Pipeline Enhancement For Generics

A conference entitled the "5th Product and Pipeline Enhancement for Generics" to be held in Washington, DC on 17-19 July will feature industry leaders in the generic, branded pharmaceutical and API industries. Issues covered will include current and upcoming changes in regulations and the market, innovation in drug pipeline, portfolio management and business development, intellectual property protection and biosimilars.

IP5 Patent Offices Strengthen Joint Work

The heads of the world's five largest intellectual property offices, who refer to themselves as the IP5, met today to discuss further efforts to improve quality and efficiency in patent examination, and harmonise patent systems. Joining them were industry representatives from each of the regions.

G8 Countries Take Hard Line On Counterfeit Medicines

The Group of Eight (G8) industrialised countries recently met to discuss major challenges to the global economy, climate change, food security and nutrition, and political and security issues. And the commitments they made on intellectual property rights reflect their current thinking on the issue.

US Licensing Experts: Innovation Is Still Happening, Let’s Help It Along

BOSTON - Early stage innovation is still strong in the United States, but parties need to work better together and address bottlenecks in the middle stages, a panel of university and private sector experts said this week. Meanwhile, the president of global biotechnology company Genzyme said the industry is not in crisis and the company is hopeful about its recent merger with Sanofi.